Mesothelioma Drug Progress

It’s good to see some progress on treating the awful diseases we call mesothelioma. It’s also good to see that progress followed and mentioned by others on the defense side of the litigation. On both topics, see this April 3, 2015 post from Ed Casmere and Emily Gesmundo at the Product Liability & Mass Torts Blog from Schiff Hardin. The post is about a new orphan drug, CRS-207, made by Aduro Biotech, Inc.


Recent Posts

See All

About Kirk

Since becoming a lawyer in 1983, Kirk’s over 30 years of practice have focused on advising a wide range of corporations, associations, and individuals (as both plaintiffs and defendants) on both tort and commercial law issues centered around “mass torts.”


Copyright © 2020, GlobalTort All Rights Reserved.